NCT06156631

Brief Summary

This study will evaluate a newly developed multimodal health intervention including dietary approach to stop hypertension (DASH) diet, exercise (Ex), and medication adherence (MA) using motivational interviewing (MI) counselling (DASH-Ex MAMI) for hypertensive Jordanian adults in primary care settings.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
126

participants targeted

Target at P50-P75 for not_applicable hypertension

Timeline
Completed

Started Jun 2024

Shorter than P25 for not_applicable hypertension

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 19, 2023

Completed
16 days until next milestone

First Posted

Study publicly available on registry

December 5, 2023

Completed
6 months until next milestone

Study Start

First participant enrolled

June 7, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 5, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 7, 2024

Completed
Last Updated

October 22, 2024

Status Verified

October 1, 2024

Enrollment Period

3 months

First QC Date

November 19, 2023

Last Update Submit

October 19, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Systolic blood pressure (SBP)

    the average measurement of systolic blood pressure in mmHg using valid automated blood pressure apparatus.

    At two points: pre-intervention (baseline) and post-intervention (after 10 weeks)

  • Diastolic blood pressure (DBP)

    the average measurement of diastolic blood pressure in mmHg using valid automated blood pressure apparatus.

    At two points: pre-intervention (baseline) and post-intervention (after 10 weeks)

Secondary Outcomes (5)

  • Dietary habits

    At two points: pre-intervention (baseline) and post-intervention (after 10 weeks)

  • Physical activity

    At two points: pre-intervention (baseline) and post-intervention (after 10 weeks)

  • Medication adherence

    At two points: pre-intervention (baseline) and post-intervention (after 10 weeks)

  • Body mass index (BMI)

    At two points: pre-intervention (baseline) and post-intervention (after 10 weeks)

  • Waist circumference (WC)

    At two points: pre-intervention (baseline) and post-intervention (after 10 weeks)

Study Arms (2)

Participants receive DASH-ExMAMI intervention.

EXPERIMENTAL

Jordanian participants who are adults (age between ≥ 18 and 65 years), have had diagnosed with hypertension and has started his or her treatment plan, and have uncontrolled hypertension (The average systolic blood pressure reading that is equal to or higher than 130 mmHg and/or diastolic blood pressure that is equal to or higher than 90 mmHg for the last two patients' records available at the health centre.

Behavioral: DASH-ExMAMI

Participants who do not receive DASH-Ex MAMI

NO INTERVENTION

Jordanian participants who are adults (age between ≥ 18 and 65 years), have had diagnosed with hypertension and has started his or her treatment plan, and have uncontrolled hypertension (The average systolic blood pressure reading that is equal to or higher than 130 mmHg and/or diastolic blood pressure that is equal to or higher than 90 mmHg for the last two patients' records available at the health centre.

Interventions

DASH-ExMAMIBEHAVIORAL

The DASH-ExMAMI consists of ten counseling and health education sessions that each last from 20 to 60 minutes over 10 weeks. The DASH domain will address the following subjects: getting started on DASH, making the move to DASH, tips to reduce salt and sodium, and a week with the DASH eating plan. The Exercise component consists of brisk walking for 30 minutes every day, five days a week. The medication adherence domain is based on the participant's Hill-Bone Compliance to High Blood Pressure Therapy Scale items and their scores. All domains of the intervention are stages and processes of change-matched ones and are provided through 10 motivational interviewing and counseling sessions.

Also known as: Dietary approach to stop hypertension, exercise and medication adherence behavioral change
Participants receive DASH-ExMAMI intervention.

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient's age between ≥ 18 and 65 years old.
  • Has had diagnosed with hypertension and has started his or her treatment plan.
  • Has uncontrolled hypertension: The average systolic blood pressure reading that is equal to or higher than 130 mmHg and/or diastolic blood pressure that is equal to or higher than 90 mmHg for the last two patients' records available at the health center.
  • Has no other comorbidities that contraindicate exercise or restrict DASH diet.
  • Written medical authorization (documented in patient's medical record) by the attending primary healthcare physician approving the patient's participation.

You may not qualify if:

  • Pregnant and postpartum women
  • Has severe hypertension (SBP≥ 200 or DBP ≥110). Resting SBP greater than 200mm Hg or DBP greater than 110mm Hg is a relative contraindication to exercise stress testing.
  • Has history of cardio-pulmonary, renal, or musculoskeletal comorbidities that contraindicate exercise or DASH diet.
  • This research will exclude all clients who are contraindicated to undergo treadmill tests with extra precautions: history of myocardial infarction within six months, angina, cardiac dysrhythmias, symptomatic aortic stenosis, and heart failure, pulmonary embolus, infarction or hypertension, myocarditis or pericarditis, or endocarditis, aortic dissection, history of renal impairment, brittle diabetes mellitus, bronchial asthma, musculoskeletal problems that might worsen by exercise, and mental health problems that interfere with the comprehension of the intervention and its related safety measures. Clients with a history of metabolic disorders and who follow a specific diet restriction will also be excluded such as celiac disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Al Barha Health Center

Irbid, 21191, Jordan

Location

Al Tattweer Al Hadhary Health Center

Irbid, 21191, Jordan

Location

Al Zahrawi Health Center

Irbid, 21191, Jordan

Location

Maruw Health Center

Irbid, 21191, Jordan

Location

MeSH Terms

Conditions

HypertensionMotor ActivityFeeding BehaviorMedication Adherence

Interventions

Exercise

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesBehaviorBehavior, AnimalPatient CompliancePatient Acceptance of Health CareTreatment Adherence and ComplianceHealth Behavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
A single-blind method will be used for the main outcome measure (BP) in this study. Blood pressure and the anthropometric measurements (height, weight, and waist circumference) will be assessed by a research assistant who doesn't know which group a participant belongs to. However, an open-label method will be applied for the other outcome measures: dietary habits, physical activity, and medication adherence.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: A Quasi-experimental design will be used to test the efficacy of the intervention (DASH-ExMAMI) on participants. The participants will be allocated into experimental and control groups. The experimental group will complete dietary, physical activity, medication adherence, and anthropometric assessments before and after the intended intervention. Similarly, the control group will be subjected to dietary, physical activity, medication adherence, and anthropometric assessments before and after the intervention, as in the experimental group but receiving only a usual care (UC) as provided by the PHC. The intervention (DASH-ExMAMI) will last ten weeks (ten sessions) and will include DASH dietary instruction and meal planning, self-monitored brisk walking exercise, and a medication adherence intervention based on an individual MI counselling approach.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD student

Study Record Dates

First Submitted

November 19, 2023

First Posted

December 5, 2023

Study Start

June 7, 2024

Primary Completion

September 5, 2024

Study Completion

October 7, 2024

Last Updated

October 22, 2024

Record last verified: 2024-10

Locations